Lymphatic Vessels and Lymph Transport
Development of the Lymphatic System
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Chaonan Zhang1, Jing Liu2, Yao Wang2
1School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, P.R. China; Laboratory of Translational Medicine in Microvascular Regulation, Medical Research Center, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, P.R. China; Shandong Provincial Key Medical and Health Laboratory of Translational Medicine in Microvascular Aging, Jinan, Shandong, P.R. China; Laboratory of Future Industry of Gene Editing in Vascular Endothelial Cells of Universities in Shandong Province, Jinan, Shandong, P.R. China.
淋巴发育不良 (LM) 是由影响PI3K/AKT/mTOR和VEGF等关键信号通路的遗传突变驱动的淋巴系统瘤. 目前的治疗包括mTOR抑制剂和VEGFR-3抑制剂,为患者提供了新的希望.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: